Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHermes Pac. Regulatory News (HPAC)

Share Price Information for Hermes Pac. (HPAC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 47.50
Bid: 40.00
Ask: 55.00
Change: 0.00 (0.00%)
Spread: 15.00 (37.50%)
Open: 47.50
High: 47.50
Low: 47.50
Prev. Close: 47.50
HPAC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

22 Sep 2021 07:00

RNS Number : 5178M
Hermes Pacific Investments PLC
22 September 2021
 

22 September 2021

HERMES PACIFIC INVESTMENTS PLC

(AIM:HPAC)

Final results for the year ended 31 March 2021

 

Hermes Pacific Investments Plc today reports its financial results for the year ended 31 March 2021

 

Chairman's Statement

 

I am pleased to report the results of Hermes Pacific Investments Plc ("HPAC" or the "Company") for the year ended 31 March 2021. During the year, the Company had no revenues as it does not have any operating business and the Company made a loss of £106,000, which is higher than the loss of £94,000 reported for the previous financial year. We continue our focus to minimise our costs whilst we are looking for opportunities to deploy our cash. At the financial year end the Company had net assets of £3,554,000.

 

Review of the Company's Activities

 

The Company is an investing company and has previously made some investments in line with its investing policy in companies involved in financial activities within the emerging market sector. These investments have performed in line with our expectations. We are in a good position from a Balance Sheet perspective and our cash balance as at 31 March 2021 stands at £3.395 million. During the year we have continued to evaluate possible suitable opportunities to deploy our cash resources but have not found any deal that met our criteria. Our total comprehensive loss for the year was £55,000 compared to a loss of £133,000 for the previous financial year. The deficit is lower this year compared to last year as there was a gain of £51,000 on investments held by the Company.

 

Stock markets overall have performed well in the last year driven by rapid successful vaccinations in many countries and recovering economies and this has resulted in some lofty valuations. The stronger than expected recovery in the economy has raised fears of inflation rising. Inflation is certainly a big risk factor threatening a continuation of the rally in equities that we have seen. Recent trading updates from companies have mentioned inflation as a key risk. Some economists argue that the current factors affecting rising inflation are likely to be transitory and that conditions for a longer-term regime shift in inflation aren't in place. Whilst inflation has been low for a while it could quickly turn around. This could then force the hand of central banks use their interest rate levers that would launch major economies on a potentially painful rate hike spiral.

 

John Berry stepped down from the board on 28 February 2021. On behalf of the board I would like to thank John Berry for 9 years of service to the company and his significant contributions to the company. We would like to wish John Berry well for the future.

 

The Company continues to seek attractive investment opportunities that will enhance the shareholder value while minimising the downside risks.

 

Outlook

We have a strong balance sheet and cash resources that place us in a strong position to exploit investment opportunities as they arise.

 

Haresh Kanabar

Chairman

 

22 September 2021

 

Contacts

 

Hermes Pacific Investments Plc

www.hermespacificinvestments.com

Haresh Kanabar, Non-Executive Chairman

Tel: +44 (0) 207 290 3340

 

 

WH Ireland Limited (Nominated Adviser & Broker)

www.whirelandcb.com

Mike Coe/ Chris Savidge

Tel: +44 (0) 117 945 3470

 

Statement of Comprehensive Income for the year ended 31 March 2021

 

 

 

Year ended

31 March

 

Year ended

31 March

 

Note

2021

2020

 

 

£'000

£'000

 

 

 

 

Continuing operations

 

 

 

Revenue

 

-

-

Cost of sales

 

-

-

 

 

gross profit

 

-

-

 

 

 

 

Other operating income

 

-

-

Administrative expenses

3

(114)

(113)

 

 

Operating loss

 

(114)

(113)

 

 

 

 

Finance income

 

8

19

Finance costs

 

-

-

 

 

Loss on ordinary activities before tax

 

(106)

(94)

 

 

 

 

Tax expense

7

-

-

 

 

Loss for the year from continuing activities

 

(106)

 

(94)

 

Discontinued operations

 

 

Loss for the year from discontinued operations

 

-

-

 

 

Loss for the year

 

(106)

(94)

 

Other comprehensive income

Gain/(losses) arising in the year on investments

 

Total comprehensive loss for the year

 

 

 

 

51

(55)

 

 

(39)

(133)

 

Basic and diluted loss per share

 

 

 

From continuing operations

8

(4.5)p

(4.0)p

 

Statement of Financial Position as at 31 March 2021

 

 

 

As at

31 March

 

As at

31 March

 

 

2021

2020

 

Notes

£'000

£'000

ASSETS

 

 

 

Non-current assets

 

 

 

Investments

9

173

123

 

 

 

 

173

123

Current assets

 

 

 

Trade and other receivables

11

9

9

Cash and cash equivalents

10

3,395

3,506

 

 

 

 

3,404

3,515

LIABILITIES

 

 

 

Current liabilities

 

 

 

Trade and other payables

12

(23)

(29)

 

 

 

 

(23)

(29)

 

 

Net current assets

 

3,381

3,486

 

 

NET ASSETS

 

3,554

3,609

 

 

SHAREHOLDERS' EQUITY

 

 

 

Issued share capital

13

3,576

3,576

Share premium account

 

5,781

5,781

Share based payments reserve

Fair value reserve

 

139

1

139

(50)

Retained earnings

 

(5,943)

(5,837)

 

 

TOTAL EQUITY

 

3,554

3,609

 

 

 

 

 

 

 

Cash Flow Statement for the year ended 31 March 2021

 

Note

Year ended

31 March 2021

Year ended

31 March 2020

 

 

£'000

£'000

 

 

 

 

Cash flows from operating activities

15

(119)

(109)

 

 

 

 

Cash flows from investing activities

 

 

 

Acquisition of investments

 

-

-

Income from disposal of subsidiary undertakings

 

-

-

Investment income

 

8

19

 

 

Net cash (used in)/from investing activities

 

8

19

 

 

Cash flows from financing activities

 

 

 

Proceeds of share issues

Other operating activities

 

-

-

-

-

 

 

Net cash from financing activities

 

-

-

 

 

 

 

(Decrease)/increase in cash and cash equivalents

 

(111)

(90)

Cash and cash equivalents at start of period

10

3,506

3,596

 

 

 

Cash and cash equivalents at end of period

 

10

 

3,395

 

3,506

 

 

 

 

 

 

 

 

Statement of Changes in Equity for the year ended 31 March 2021

 

 

 

 

Ordinary share capital

 

Deferred share capital

 

 

Share premium

Share

based payments reserve

 

 

Retained earnings

 

 

Revaluation reserve

 

 

 

Total

At 1 April 2019

2,333

1,243

5,781

 

139

(5,743)

(11)

3,742

Total comprehensive loss/profit for the

period

-

-

-

-

(94)

(39)

(133)

 

   

 

 

 

   

 

At 1 April 2020

 

2,333

1,243

5,781

139

(5,837)

(50)

3,609

Total comprehensive loss for the

period

-

-

-

-

(106)

51

(55)

 

 

   

 

 

 

   

 

At 31 March 2021

2,333

1,243

5,781

139

(5,943)

1

3,554

 

 

 

Notes to the financial statements for the year ended 31 March 2021

 

1. General information

Hermes Pacific Investments Plc is a company incorporated in the United Kingdom under the Companies Act 2006. The nature of the company's operations and its principal activities are set out in the Directors' Report on page 4.

 

Statement of compliance

 

The Group financial statements were prepared in accordance with international accounting standards in conformity with the requirements of the Companies Act 2006.

 

At the date of approval of these financial statements, various Standards and Interpretations affecting the Company, which have not been applied in these financial statements, were in issue, but not yet effective (and in some cases had not been adopted by the EU). The Directors have considered these new standards and interpretations and do not expect them to have a material impact on the company.

 

2. Accounting policies

 

The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.

 

Going concern

The financial statements have been prepared on a going concern basis as, after making appropriate enquiries, the Directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future at the time of approving the financial statements. The outbreak of Covid 19 which has spread globally does not have any impact on our going concern status as we have sufficient cash to fund our activities in the foreseeable future.

 

Critical accounting estimates and judgments

The preparation of financial statements in conformity with IFRS requires management to make judgements, estimates and assumptions that affect the application of the company's accounting policies with respect to the carrying amounts of assets and liabilities at the date of the financial statements, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting year. The judgements, estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, including current and expected economic conditions. Although these judgements, estimates and associated assumptions are based on management's best knowledge of current events and circumstances, the actual results may differ. Estimates and underlying assumptions are reviewed on an on-going basis. Revisions to accounting estimates are recognised in the year in which the estimate is revised and in any future years affected.

 

Management have not made any material estimates or judgements that may result in a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year.

 

Deferred taxation

Deferred taxation is provided in full using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts in the consolidated financial statements. Deferred tax is determined using tax rates that have been enacted or substantially enacted by the balance sheet date and are expected to apply when the related deferred tax asset is realised, or the deferred tax liability is settled.

 

Deferred tax assets are recognised to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilised.

 

Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short term highly liquid funds with original maturities of three months or less and bank overdrafts.

 

Investments

The company carries its investments at fair value. Gains and losses are either recorded in profit or loss or other comprehensive income. For investments in equity instruments that are not held for trading, this will depend on whether the company has made an irrevocable election at the time of initial recognition to account for the equity investment at fair value through other comprehensive income.

 

Financial instruments

Financial assets and liabilities are recognised in the balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Trade and other receivables

Trade receivables are measured at cost less any provision necessary when there is objective evidence that the company will not be able to collect all amounts due.

 

Trade and other payables

Trade and other payables are not interest bearing and are measured at original invoice amount.

 

3. Operating loss

 

 

 

Year ended

 31 March 2021

 

 

Year ended

 31 March 2020

 

 

£'000

 

£'000

 

The operating loss is stated after charging the following, included in administrative expenses:

 

 

 

 

Staff costs

43

 

44

 

Other admin costs

71

 

69

 

 

 

 

 

114

 

113

 

 

 

 

 

4. Auditors' remuneration

 

 

 

Year ended

 31 March 2021

 

Year ended

 31 March 2020

 

 

 

£'000

 

£'000

 

 

Audit fees:

 

 

 

 

 

- statutory audit of the accounts

12

 

12

 

 

 

 

 

 

 

12

 

12

 

 

 

 

 

 

 

5. Directors' emoluments

 

 

Year ended

 31 March 2021

 

Year ended

 31 March 2020

 

 

£'000

 

£'000

 

 

 

 

 

 

Emoluments for qualifying services:

 

 

 

 

H Kanabar

22

 

22

 

J Berry

9

 

10

 

J Morton

12

 

12

 

 

 

 

 

43

 

44

 

 

 

 

 

 

 

 

 

6. Employees and staff costs

The company has no employees. Staff costs comprises payments made in respect of services provided by the directors.

 

7. Taxation

 

 

Year ended

 31 March 2021

 

Year ended

31 March 2020

 

 

£'000

 

£'000

 

Continuing operations:

 

 

 

 

Current tax charge

-

 

-

 

Adjustment in respect of prior years

-

 

-

 

 

 

 

Current tax credit

-

 

-

 

 

 

 

 

Factors affecting the tax charge for the period

 

 

 

 

Loss from continuing operations before taxation

(106)

 

(94)

 

 

 

 

 

 

Loss from continuing operations before taxation multiplied by standard rate of corporation tax of 19% (2020: 19%)

(20)

 

(18)

 

 

 

 

 

 

Effects of:

 

 

 

 

Temporary timing differences

-

 

-

 

Non deductible expenses

-

 

-

 

Depreciation in excess of capital allowances

-

 

-

 

Unutilised tax losses

20

 

18

 

 

 

 

Current tax charge

-

 

-

 

 

 

 

The company has approximately £4m (2020: £3.9m) of trading losses to carry forward and offset against future trading profits

 

8. Loss per share

 

 

 

Year ended

 31 March 2021

 

Year ended

 31 March 2020

 

Basic

 

 

 

 

Loss from continuing activities (£'000)

(106)

 

(94)

 

 

 

 

 

(106)

 

(94)

 

 

 

 

 

 

Number of shares

2,333,295

 

2,333,295

 

 

 

 

Basic loss per share (p)

 

 

 

 

From continuing operations

(4.5)p

 

(4.0)p

 

 

 

 

 

(4.5)p

 

(4.0)p

 

 

 

 

 

 

 

 

 

9. Investments

 

 

 

 

 

 

Investments

 

 

 

 

 

£'000

 

Cost or valuation

 

 

 

 

 

Brought forward

Fair value movement

 

 

 

 

123

50

 

 

 

 

 

 

At 31 March 2021

 

 

 

173

 

 

 

 

 

The directors have elected to hold the investments at fair value through OCI as it is their intention to hold these for the long term

 

10. Cash and cash equivalents

 

 

 

 

 

 

2021

2020

 

 

 

 

 

£'000

£'000

 

 

 

 

 

 

 

 

Cash at bank and in hand

 

 

 

3,395

3,506

 

 

 

 

 

 

 

 

 

 

3,395

3,506

 

 

 

 

 

 

 

 

 

 

 

 

Cash, cash equivalents and bank overdrafts include the following for the purposes of the cash flow statement:

 

 

 

 

 

2021

2020

 

 

 

 

 

£'000

£'000

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

3,395

3,506

 

 

 

 

 

 

 

 

 

 

3,395

3,506

 

 

 

 

 

 

 

 

 

 

 

 

 

11. Trade and other receivables

 

 

 

 

 

 

2021

2020

 

 

 

 

 

£'000

£'000

 

 

 

 

 

 

 

 

Other receivables

 

 

 

9

9

 

 

 

 

 

 

 

 

 

 

9

9

 

 

 

 

 

 

12. Trade and other payables

 

 

 

 

 

 

2021

2020

 

 

 

 

 

£'000

£'000

 

 

 

 

 

 

 

 

Trade payables

 

 

 

8

11

 

Accruals and deferred income

 

 

 

15

18

 

 

 

 

 

 

 

 

 

 

23

29

 

 

 

 

 

 

 

13. Share capital

 

 

 

2021

2020

 

 

£'000

£'000

 

Issued and fully paid

 

 

 

 

2,333,295 ordinary shares of 100p each

 

2,333

 

2,333

 

13,079,850 deferred shares of 9.5p each

1,243

1,243

 

 

 

 

3,576

3,576

 

 

 

All ordinary shares rank equally in respect of shareholders' rights.

 

The deferred shares have no voting and dividend rights. On winding up of the company, they will be entitled to the nominal value only after all ordinary shareholders receive the nominal value of their shares plus £10m per share.

 

As at 31 March 2021and 31 March 2020 the authorised share capital was 3,500,000 ordinary shares of 100p and 200,000,000 deferred shares of 9.5p.

 

14. Financial Instruments

 

Financial risk management

The company's activities expose the company to a number of risks including credit risk, interest rate risk and liquidity risk. The Board manages these risks through a risk management programme. The fair value of the company's assets and liabilities at 31 March 2021 are not materially different from their book value.

 

 

 

 

2021

 

2020

 

 

£'000

£'000

 

 Financial assets at fair value

 through other comprehensive income

 

 

 

173

 

 

123

 

 

 

173

123

 

 

 

 

 

 

The fair value measured is categorised within level 1 of the fair value hierarchy.

 

 

 

Financial assets at amortised cost

 

2021

 

2020

 

 

£'000

£'000

 

 

Loan and receivables:

 

 

 

Trade and other receivables

9

9

 

Cash and cash equivalents

3,395

3,506

 

 

 

 

3,404

3,515

 

 

 

 

Financial liabilities at amortised cost

 

 

2021

 

2020

 

 

 

£'000

£'000

 

Trade and other payables

 

 

23

 

29

 

 

 

23

29

 

 

Credit risk

The company monitors credit risk on an on-going basis and manages risk by concentrating on trading and placing bank deposits with reliable counterparties. The company has no significant concentration of credit risk associated with trading counterparties. Credit risk predominantly arises from cash and cash equivalents.

 

Interest rate risk

The company has interest bearing assets. Interest bearing assets comprise cash balances which earn interest at a variable rate. The financial liabilities in the current year are all non-interest bearing. The company has not entered into derivatives transactions and has not traded in financial instruments during the period under review. The entire company's debt is non-interest bearing there would be no effect on the company if interest rates changed.

 

Liquidity risk

The company seeks to manage liquidity risk by ensuring sufficient liquidity is available to meet foreseeable needs and to invest cash assets safely and profitably. All cash and cash equivalents are immediately accessible.

 

Price risk

The company's exposure to equity securities price risk arises from investments held by the company and classified in the statement of financial position either as at fair value through other comprehensive income or at fair value through profit or loss. The risk is managed by regular reviews of the portfolio of investments held to ensure that exposure to price movements is within acceptable limits.

 

The maturity dates of the company's financial instruments are shown below and are based on the period outstanding at the balance sheet date up to the contractual maturity date.

 

 

 

Less than

6 months

Between

6 months and 1 year

Between

1 and 5 years

 

 

Total

 

£'000

£'000

£'000

£'000

2021

 

 

 

 

Financial Assets

 

 

 

 

Variable interest rate instruments

3,395

-

-

3,395

Non-interest bearing

-

9

-

9

 

 

3,395

9

-

3,404

 

Financial Liabilities

 

 

 

 

Non-interest bearing

23

-

-

23

 

 

23

-

-

23

 

 

 

 

 

 

Less than

6 months

Between

6 months and 1 year

Between

1 and 5 years

 

 

Total

 

£'000

£'000

£'000

£'000

2020

 

 

 

 

Financial Assets

 

 

 

 

Variable interest rate instruments

3,506

-

-

3,506

Non-interest bearing

-

9

-

9

 

 

3,506

9

-

3,515

 

 

Financial Liabilities

Non-interest bearing

 

 

29

 

 

-

 

 

-

 

 

29

 

 

29

-

-

29

 

 

 

15. Cash flows from operating activities

 

Year ended

31 March 2020

Year ended

31 March 2020

 

£'000

£'000

 

 

 

Loss on ordinary activities before tax

(114)

(113)

Depreciation of property, plant and equipment

-

-

 

Operating cash flows before movements in working capital

(114)

(113)

Decrease in trade and other receivables

-

(8)

(Decrease)/Increase in trade and other payables

(5)

12

 

Cash flows from operating activities

(119)

(109)

 

 

 

 

 

16. Related party transactions

 

Key Management Personnel and Director Transactions

A number of key management personnel, or their related parties, hold positions in other entities that result in them having control or significant influence over the financial and operating policies of these entities.

 

A number of these entities transacted with the company during the year. The terms and conditions of these transactions with key management personnel and their related parties were no more favourable than those available, or which might reasonably be expected to be available, on similar transactions to non-key management personnel related entities on an arm's length basis.

 

The aggregate value of transactions related to key management personnel and entities over which they have control or significant influence was £42,800 (2020: £43,600).

 

During the year, the company used the services of Poonam & Roshni Limited totalling £21,600 (2020: £21,600). H Kanabar is a director of both companies. No balance was outstanding at the year end (2020: Nil).

 

During the year the company used the services of John Berry Associates Limited totalling £9,000 (2020: £10,000). J Berry resigned on 28 February 2021 but was a director of both companies. No balance was outstanding at the year end (2020: Nil).

 

During the year the company used the services of Thirty Acre Stables totalling £12,000 (2020: £12,000). J Morton is the owner of that business. No balance was outstanding at the year end (2020: Nil).

 

The compensation of key management is as disclosed in the directors' emoluments note.

 

17. Annual report

The Annual Report will be posted to shareholders shortly and will be available on the Company's website http://www.hermespacificinvestments.com. Copies will be available thereafter in hard copy format from the Company's registered office, 22 Great James Street, London WC1N 3ES.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR UASNRASUKUAR
Date   Source Headline
15th Dec 20237:00 amRNSInterim Results
26th Sep 202312:00 pmRNSFinal Results
20th Dec 20227:00 amRNSInterim Results
26th Sep 20227:00 amRNSFinal Results
19th May 20227:00 amRNSProperty purchase
14th Dec 202112:37 pmRNSResult of General Meeting
13th Dec 20217:00 amRNSInterim Results
22nd Nov 20217:00 amRNSProposed Change of Investing Policy
22nd Sep 20217:00 amRNSFinal Results
3rd Feb 20213:11 pmRNSDirectorate Change
18th Dec 20207:00 amRNSInterim results
28th Sep 20207:00 amRNSFinal Results
20th Dec 20197:00 amRNSHalf-year Report
6th Nov 20191:18 pmRNSResult of AGM
3rd Oct 201911:15 amRNSNotice of AGM
24th Sep 201910:15 amRNSFinal Results
20th Dec 20188:41 amRNSHalf-year Report
12th Sep 20184:20 pmRNSFinal Results
13th Dec 20177:00 amRNSHalf-year Report
21st Sep 20177:00 amRNSFinal Results
19th Dec 20167:00 amRNSHalf-year Report
22nd Sep 201612:00 pmRNSFinal Results
21st Dec 20158:00 amRNSHalf Yearly Report
30th Oct 201511:38 amRNSResult of AGM
18th Sep 20157:00 amRNSFinal Results
22nd Dec 20147:00 amRNSInterim Results
30th Sep 20147:00 amRNSFinal Results
16th Dec 20137:00 amRNSHalf Yearly Report
30th Sep 20137:00 amRNSFinal Results
9th Sep 201312:03 pmRNSApproval of Share Consolidation
16th Aug 20137:00 amRNSProposed Share Consolidation
18th Jul 201312:44 pmRNSIssue of Equity
21st Dec 20127:00 amRNSHalf Yearly Report
25th Oct 201211:47 amRNSResult of AGM
12th Oct 20127:00 amRNSChange of Registered Office
28th Sep 20127:00 amRNSFinal Results
17th Sep 20127:00 amRNSDirectorate Changes
31st Aug 201211:00 amRNSNew Investments
23rd Aug 201211:00 amRNSNew Investments, Change of Reg Office & Website
21st Aug 20127:00 amRNSName Change Effective
20th Aug 20122:30 pmRNSResult of GM
27th Jul 20121:00 pmRNSIssue of Equity, Directorate Changes, GM Notice
5th Jul 201211:55 amRNSHolding(s) in Company
31st May 20124:43 pmRNSHolding(s) in Company
8th May 20123:39 pmRNSHolding(s) in Company
24th Jan 20122:30 pmRNSHolding(s) in Company
16th Dec 20117:00 amRNSHalf Yearly Report
28th Sep 20117:30 amRNSRestoration - Indian Restaurants Group Plc
28th Sep 20117:00 amRNSFinal Results
26th Aug 20111:00 pmRNSResult of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.